Akso Health Group
AHG
$1.28
-$0.12-8.57%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Revenue | 0.93% | 0.93% | 415.75% | 415.75% | 675.98% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 0.93% | 0.93% | 415.75% | 415.75% | 675.98% |
| Cost of Revenue | -5.42% | -5.42% | 478.67% | 478.67% | 688.65% |
| Gross Profit | 223.03% | 223.03% | -668.59% | -668.59% | 396.91% |
| SG&A Expenses | 180.91% | 180.91% | -54.60% | -54.60% | -68.85% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 12.86% | 12.86% | 43.13% | 43.13% | 132.91% |
| Operating Income | -165.79% | -165.79% | 46.50% | 46.50% | 76.65% |
| Income Before Tax | -180.16% | -180.16% | -2,638.33% | -2,638.33% | 83.08% |
| Income Tax Expenses | -456.41% | -456.41% | -15,420,100.00% | -15,420,100.00% | 57.26% |
| Earnings from Continuing Operations | -135.35% | -135.35% | -2,128.84% | -2,128.84% | 81.96% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | 174.56% | 174.56% | 800.00% | 800.00% | -5,533.33% |
| Net Income | -117.49% | -117.49% | -2,139.40% | -2,139.40% | 83.03% |
| EBIT | -165.79% | -165.79% | 46.50% | 46.50% | 76.65% |
| EBITDA | 59.34% | 59.34% | -- | -- | -- |
| EPS Basic | 15.38% | 15.38% | -374.52% | -374.52% | 98.28% |
| Normalized Basic EPS | 12.50% | 12.50% | 91.19% | 91.19% | 98.07% |
| EPS Diluted | 0.00% | 0.00% | -320.17% | -320.17% | 98.02% |
| Normalized Diluted EPS | 12.50% | 12.50% | 91.19% | 91.19% | 98.07% |
| Average Basic Shares Outstanding | 152.81% | 152.81% | 371.72% | 371.72% | 919.05% |
| Average Diluted Shares Outstanding | 152.81% | 152.81% | 371.72% | 371.72% | 919.05% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |